The roles of 2-oxoglutarate (2OG)-dependent prolyl-hydroxylases in eukaryotes include collagen stabilization, hypoxia sensing, and translational regulation. The hypoxia-inducible factor (HIF) sensing system is conserved in animals, but not in other organisms. However, bioinformatics imply that 2OG-dependent prolyl-hydroxylases (PHDs) homologous to those acting as sensing components for the HIF system in animals occur in prokaryotes. We report cellular, biochemical, and crystallographic analyses revealing that Pseudomonas prolyl-hydroxylase domain containing protein (PPHD) contain a 2OG oxygenase related in structure and function to the animal PHDs. A Pseudomonas aeruginosa PPHD knockout mutant displays impaired growth in the presence of iron chelators and increased production of the virulence factor pyocyanin. We identify elongation factor Tu (EF-Tu) as a PPHD substrate, which undergoes prolyl-4-hydroxylation on its switch I loop. A crystal structure of PPHD reveals striking similarity to human PHD2 and a Chlamydomonas reinhardtii prolyl-4-hydroxylase. A crystal structure of PPHD complexed with intact EF-Tu reveals that major conformational changes occur in both PPHD and EF-Tu, including a >20-Å movement of the EF-Tu switch I loop. Comparison of the PPHD structures with those of HIF and collagen PHDs reveals conservation in substrate recognition despite diverse biological roles and origins. The observed changes will be useful in designing new types of 2OG oxygenase inhibitors based on various conformational states, rather than active site iron chelators, which make up most reported 2OG oxygenase inhibitors. Structurally informed phylogenetic analyses suggest that the role of prolylhydroxylation in human hypoxia sensing has ancient origins.
The roles of 2-oxoglutarate (2OG)-dependent prolyl-hydroxylases in eukaryotes include collagen stabilization, hypoxia sensing, and translational regulation. The hypoxia-inducible factor (HIF) sensing system is conserved in animals, but not in other organisms. However, bioinformatics imply that 2OG-dependent prolyl-hydroxylases (PHDs) homologous to those acting as sensing components for the HIF system in animals occur in prokaryotes. We report cellular, biochemical, and crystallographic analyses revealing that Pseudomonas prolyl-hydroxylase domain containing protein (PPHD) contain a 2OG oxygenase related in structure and function to the animal PHDs. A Pseudomonas aeruginosa PPHD knockout mutant displays impaired growth in the presence of iron chelators and increased production of the virulence factor pyocyanin. We identify elongation factor Tu (EF-Tu) as a PPHD substrate, which undergoes prolyl-4-hydroxylation on its switch I loop. A crystal structure of PPHD reveals striking similarity to human PHD2 and a Chlamydomonas reinhardtii prolyl-4-hydroxylase. A crystal structure of PPHD complexed with intact EF-Tu reveals that major conformational changes occur in both PPHD and EF-Tu, including a >20-Å movement of the EF-Tu switch I loop. Comparison of the PPHD structures with those of HIF and collagen PHDs reveals conservation in substrate recognition despite diverse biological roles and origins. The observed changes will be useful in designing new types of 2OG oxygenase inhibitors based on various conformational states, rather than active site iron chelators, which make up most reported 2OG oxygenase inhibitors. Structurally informed phylogenetic analyses suggest that the role of prolylhydroxylation in human hypoxia sensing has ancient origins.
T he hypoxia-inducible transcription factor (HIF) is a major regulator of the response to limited oxygen availability in humans and other animals (1) (2) (3) . A hypoxia-sensing component of the HIF system is provided by 2-oxoglutarate (2OG)-dependent and Fe(II)-dependent oxygenases, which catalyze prolyl-4-hydroxylation of HIF-α subunits, a posttranslational modification that enhances binding of HIF-α to the von Hippel-Lindau protein (pVHL), so targeting HIF-α for proteasomal degradation. The HIF prolyl-hydroxylases (PHDs) belong to a subfamily of 2OG oxygenases that catalyze prolyl-hydroxylation, which also includes the collagen prolyl-3-hydroxylases (CP3Hs) and prolyl-4-hydroxylases (CP4Hs) (4) . Subsequently identified prolyl-hydroxylases include the ribosomal prolyl-hydroxylases (OGFOD1 and Tpa1), which catalyze ribosomal protein 23 prolyl-3-hydroxylation in many eukaryotes, and slime-mold enzymes, which catalyze prolyl-4-hydroxylation of Skp1, a ubiquitin ligase subunit (5) (6) (7) (8) (9) . The HIF-PHD-VHL triad is likely present in all animals, but probably not in other organisms (3) . However, structurally informed bioinformatic analyses imply the presence of PHD homologs in bacteria (10, 11) , including in Pseudomonas spp, suggesting PHDs may have ancient origins.
Results
Pseudomonas spp. Contain a Functional PHD. To investigate the role of a putative PHD homolog in Pseudomonas aeruginosa (PPHD), we initially characterized a PPHD insertional mutant strain. Metabolic screening studies revealed that the PPHD mutant strain displays impaired growth in the presence of iron chelators (e.g., 2,2-bipyridine) and produces increased levels of the bacterial virulence factor pyocyanin (SI Appendix, Fig. S1 ) (12) , implying PPHD is involved in iron regulation. Ferrous iron is essential for PHD catalysis and treatment of human cells with iron chelators,
Significance
The Fe(II)-and 2-oxoglutarate (2OG)-dependent hypoxiainducible transcription factor prolyl-hydroxylases play a central role in human oxygen sensing and are related to other prolylhydroxylases involved in eukaryotic collagen biosynthesis and ribosomal modification. The finding that a PHD-related prolyl-hydroxylase in Pseudomonas spp. regulates pyocyanin biosynthesis supports prokaryotic origins for the eukaryotic prolyl-hydroxylases. The identification of the switch I loop of elongation factor Tu (EF-Tu) as a Pseudomonas prolyl-hydroxylase domain containing protein (PPHD) substrate provides evidence of roles for 2OG oxygenases in both translational and transcriptional regulation. A structure of the PPHD:EF-Tu complex, the first to the authors' knowledge of a 2OG oxygenase with its intact protein substrate, reveals that major conformational changes occur in both PPHD and EF-Tu and will be useful in the design of new prolylhydroxylase inhibitors.
including pyocyanin (13) , and causes HIF-α up-regulation via PHD inhibition, suggesting related roles for PPHD and the animal PHDs (1).
Elongation Factor Tu Is a PPHD Substrate. We then investigated possible PPHD substrates. Mass spectrometric (MS) studies identified elongation factor Tu (EF-Tu) as a PPHD binding partner and potential substrate in Pseudomonas putida (SI Appendix, Table S3 ). This assignment is supported by a proteomic MS study on Shewanella oneidensis, reporting that EF-Tu is modified by a +16-Da mass shift (14) ; bioinformatics reveal Shewanella oneidensis contains a potential hydroxylase closely related to PPHD (38% identity). We tested a set of 14 synthetic peptides covering the 19 prolines in the EF-Tu sequence as substrates for isolated recombinant PPHD putida (SI Appendix, Table S4 ). We identified an EF-Tu peptide as undergoing a +16-Da mass shift (Fig. 1B and SI Appendix, Table S4 ); MSMS analyses demonstrated hydroxylation at Pro54 (Hyp54; SI Appendix, Fig. S2A ). Amino acid analyses reveal that PPHD putida catalyzes trans prolyl-4-hydroxylation of EF-Tu, as occurs for PHD-catalyzed HIF and CP4H-catalyzed collagen prolyl-hydroxylation (SI Appendix, Fig. S2B ) (1). We did not observe cross hydroxylation reactivity between the PPHD and PHD2 substrates; that is, EFTu with PHD2 and the C-terminal oxygen degradation domain (CODD) of HIF-1α (CODD 556-574 ) with PPHD.
EF-Tu undergoes hydroxylation in the wild-type but not in the PPHD insertional mutant strain, as shown by MS studies (SI Appendix, Fig. S3A and B). Because the human elongation factor 2 (eEF2) interacts with PHD2 (15), we tested peptides derived from the switch I loop of human eEF2 as potential PPHD or PHD2 substrates but did not observe hydroxylation within the limits of detection.
Effect of Prolyl-Hydroxylation on EF-Tu Function. Kinetic analyses were then carried out using a 20-residue EF-Tu fragment (EF-Tu [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] ). Compared with an analogous substrate fragment with PHD2, PPHD putida has a similar apparent K m (47.2 ± 8.5 μM for PPHD/EF-Tu 44-63 ; 36.7 ± 9.0 μM for PHD2/HIF-1α CODD), but a lower apparent K m for O 2 (47.5 ± 9.2 μM for PPHD/EF-Tu [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] ; 229 ± 60 μM for PHD2/HIF-1α CODD), and higher apparent K m values for 2OG (182 ± 22 μM for PPHD/EFTu [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] ; 55 ± 11 μM for PHD2/HIF-1α CODD), Fe(II) (6.3 ± 0.7 μM for PPHD/EF-Tu [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] ; <1 μM for PHD2/HIF-1α CODD), and L-ascorbate (1,064 ± 95 μM for PPHD/EF-Tu [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] ; 54 ± 10 μM for PHD2/HIF-1α CODD; SI Appendix, Fig. S4 A-E) (16) (17) (18) (19) (20) . Although the results with isolated enzyme may not reflect the cellular kinetics, given that PHD2 kinetics are proposed to reflect its role as a hypoxia sensor, these preliminary differences are of interest. In particular, the higher K m for Fe(II) is notable given the phenotypic results on the PPHD insertional mutant strain, supporting a role for PPHD in iron regulation.
The switch I loop of EF-Tu plays a central role in bacterial translation by coupling GTP hydrolysis with conformational changes from the GTP-bound active state to the GDP-bound inactive state (21, 22) . NMR was used to directly monitor kirromycin-induced GTP hydrolysis by EF-Tu putida ; we observed no difference in the GTP hydrolysis rate for Hyp54 EF-Tu (0.71 ± 0.02 μM/min) and unmodified EF-Tu (0.76 ± 0.08 μM/min; SI Appendix, Fig. S5A ). However, addition of PPHD putida to the EFTu GTP hydrolysis reaction decreased the rate of GTP hydrolysis in a metal ion and 2OG-dependent manner [Zn(II) 0.60 ± 0.05 μM/min; Zn(II) and 2OG 0.49 ± 0.16 μM/min; Zn(II) was used as a surrogate for Fe(II) and a PPHD putida inhibitor; SI Appendix, Fig. S5 B-D] . In P. aeruginosa, we observed no difference in the global translation rate between the PPHD mutant strain and the wild-type under standard growth conditions, as measured by [ Fig. S5E ). The effect of PPHD putida on the GTP hydrolysis rate is less with hydroxylated EF-Tu (0.83 ± 0.08 μM/min) (SI Appendix, Fig. S5B ), likely because of the weaker binding of hydroxylated EF-Tu to PPHD.
Using a paramagnetic relaxation enhancement-based NMR technique [with Mn(II) substituting for Fe(II)], we observed that addition of EF-Tu protein decreased the PPHD putida 2OG K d by ∼50-fold (8 ± 4 μM) compared with the absence of any substrate or in the presence of EF-Tu [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] (>400 μM; SI Appendix, Fig. S5F ), implying a substantial interaction interface between PPHD putida and EF-Tu. These results implied that very substantial interactions between PPHD putida and EF-Tu likely extend well beyond the immediate active site region. Notably, the observation that PPHD putida addition decreases the rate of GTP hydrolysis and the location of Pro54 on the switch I loop suggests that PPHD putida sequesters the switch I loop. We therefore pursued structural characterization of PPHD putida , EF-Tu, and the PPHD:EF-Tu complex.
Structure of PPHD. To investigate the structural similarity of PPHD putida to PHD2, we determined a crystal structure of PPHD putida complexed with Mn(II) and N-oxalylglycine (NOG), which are inert substitutes for Fe(II) and 2OG, respectively (2.0-Å resolution; space group P1). Similar to other 2OG oxygenases, PPHD putida contains a double-stranded β-helix (DSBH) core fold comprising eight β-strands (I-VIII) folded into major and minor β-sheets that enclose the metal-/2OG-binding sites ( Fig. 2A) (23, 24) . Five antiparallel β-strands [β1-β2(I)-β4(III)-β7 (VI)-β9(VIII)] form the major β-sheet, and four antiparallel β-strands [β3(II)-β5(IV)-β6(V)-β8(VII)] form the minor β-sheet. Three α-helices (α1-α3) pack against the major β-sheet of the DSBH. A disordered region (residues 47-71) of PPHD putida corresponds to the β2-β3 finger loop of PHD2, which is conformationally flexible and involved in HIF-α binding (10, 25) . PPHD putida contains a HXD...H triad of metal-binding residues (His124, Asp126, and His183), which, with the NOG oxalyl group and a water, complete octahedral metal-coordination. Although nonidentical, the PPHD putida active site is very similar to that of PHD2 (10); NOG is positioned between the major and minor β-sheets of the DSBH such that its C-5 carboxylate forms a salt bridge with Arg192 (Arg383 PHD2 ) ( Fig. 2 B and C) . The clear similarity between PPHD putida and PHD2 supports the proposal of common ancestry for the two hydroxylases (Fig. 2B ).
Structure of a PPHD:EF-Tu Complex. We determined a P. putida EF-Tu structure (2.3-Å resolution; space group C2). EF-Tu putida and Escherichia coli EF-Tu have very similar overall folds (rmsd, 1.5 Å over 353 Cα atoms) and Mg(II) binding sites in their inactive GDP-bound states ( Fig. 3A and SI Appendix, Fig. S6 A and B) (26) . The switch I loop of EF-Tu putida (residues 40-62) is disordered; this is notable because the prolyl-hydroxylated regions of HIF-α are also predicted to be disordered in solution (18) . To obtain a structure of a PPHD:EF-Tu protein-protein complex (Fig. 3 A-C) , PPHD and EF-Tu were expressed separately to prevent EF-Tu hydroxylation and then mixed, purified, and crystallized using Mn(II) and NOG to stabilize and inactivate/inhibit PPHD, and Mg(II) and GDP to stabilize EF-Tu. In the resultant PPHD:EF-Tu complex structure (2.7-Å resolution; P3 Glu5 Glu5 lu Glu5 Gl G 6 6 6 6 6 Lys5 Lys Lys Lys Lys Ly Ly Lys s5 s5 5 5 5 5 5 Ly L Ly 5 Ly L Ly Lys y 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7 7
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Arg5 Arg Arg5 Arg5 Arg5 Arg5 Arg5 A Arg5 Arg5 Arg5 Arg5 A g5 A A A A A A 9 9 9 9 9 9 9 9 9 9 9 9 9 (27) bound to enacyloxin IIA (blue sticks) and a nonhydrolyzable GTP-analog guanosine 5′-(β,γ-imido)triphosphate (GDPNP) (red). (E) Superimposition of E. coli EF-Tu (PDB ID: 1DG1) (26) and P. putida EF-Tu from the PPHD putida :EF-Tu complex; the switch I loop is highlighted (P. putida EF-Tu, blue; E. coli EF-Tu, red). (F) Superimposition of the β5(II)-β6(III) thumb loop as in isolated PPHD (green) and in the PPHD putida (magenta):EF-Tu (cyan) complex reveals reorganization of thumb residues on substrate binding: Phe128 PPHD rotates 90°to position its phenyl ring directly behind Pro54 EF-Tu ; Asp131 PPHD forms a salt bridge with Arg133 PPHD ; Asp132 PPHD rotates 180°to salt bridge to Arg234 EF-Tu of EF-Tu domain II, allowing Arg134 PPHD to hydrogen bond to Pro54 EF-Tu .
EF-Tu is in its translationally inactive GDP-bound conformational state consistent with the observed PPHD-mediated inhibition of GTP hydrolysis. PPHD putida binds EF-Tu between domain I and domains II/III, occupying a position similar to that observed for EFTu domain I in its GTP-bound active state relative to EF-Tu domains II/III (Fig. 3D) (27) . A Mg(II) ion is present in the EF-Tu nucleotide binding site, as in the EF-Tu structure without PPHD putida . Mn(II) and NOG are present in the PPHD putida active site.
In contrast to the isolated EF-Tu putida structure, in the complex, most EF-Tu switch I loop residues are ordered (16 residues disordered in isolated EF-Tu; 6 in the PPHD:EF-Tu complex). In a structure of isolated E. coli EF-Tu (in its inactive GDPbound state), all of the switch I loop residues are ordered and located on the surface of EF-Tu domain I, adopting a loop-helixloop-strand conformation (Fig. 3E) (26) . Comparison of the P. putida PPHD:EF-Tu complex crystal structure with that of E. coli EF-Tu (78% identity; rmsd, 1.2 Å over 338 Cα atoms) reveals major differences. Relative to the isolated E. coli EF-Tu structure, in the PPHD:EF-Tu complex structure, the entire EF-Tu switch I loop pivots around residues Gly41 EF-Tu and Ile61 EF-Tu , such that Pro54 EF-Tu moves 22 Å and is positioned at the apex of an extended loop projecting into the PPHD putida active site (Fig. 3E) .
In contrast to the isolated PPHD putida structure, in the PPHD:EF-Tu complex, the PPHD putida β2-β3 finger loop (residues 51-74) is ordered and encloses the EF-Tu switch I loop within the active site (Fig. 3C) . The residues at the apex of the flexible β2-β3 finger loop of PPHD putida adopt a 3 10 -helix conformation (residues 58-60). An arginine (Arg57) before the 3 10 -helix is positioned to form a salt bridge with Asp130 of the β5(II)-β6(III) "thumb" loop (seven residues, 127-133), forming a tunnel through which the EF-Tu switch I loop is threaded (Fig.  3C ). The β5(II)-β6(III) thumb loop of PPHD putida contains three arginines, three aspartates (including Asp130), and one phenylalanine, the backbone and side chains of which make interactions with domain II of EF-Tu and undergo clear conformational changes relative to their positions in the isolated PPHD putida structure (rmsd, 1.4 Å; Fig. 3F and SI Appendix, Fig. S6C ).
As indicated by the kinetic analyses in solution, the PPHD:EF-Tu structure reveals substantial enzyme-substrate contacts beyond the active site. PPHD and EF-Tu share a total interaction interface of 1,662 Å 2 (24 hydrogen bonds; 10 salt bridges), resulting in a calculated ΔG binding of ∼-9.7 kcal/mol, of which only 965 Å 2 (13 hydrogen bonds; 3 salt bridges) is accounted for by direct interactions of PPHD putida with the EF-Tu switch I loop. Other interactions include positioning the PPHD putida α3-helix into a hydrophobic pocket in the β-barrel of EF-Tu domain II formed by Phe222 EF-Tu , Ile224 EF-Tu , and Val230 EF-Tu , and burying Phe265 EF-Tu in a hydrophobic pocket formed by the side chains of Leu101 PPHD , Leu103 PPHD , and Leu177 PPHD (Fig.  3A, Inset) . These interactions collectively order the PPHD putida thumb loop, suggesting that analogous interactions between PHD2 and full-length HIFα, not observed in a PHD2:HIF-α fragment structure (25) , may occur.
Conservation of Substrate Binding by Prolyl-Hydroxylases. The positions of the β2-β3 finger loop residues in the complex are strikingly similar to those observed for PHD2 in complex with HIF-α and to a collagen prolyl-4-hydroxylase-related protein in Chlamydomonas reinhardtii (CrP4H) when complexed with a proline-rich substrate (Fig. 4 A and B and SI Appendix, Fig. S6 D and E) (25, 28) . In PHD2 and CrP4H, the β2-β3 finger loop (PHD2: 23 residues, 236-258; CrP4H: 24 residues, 76-99) and β5 (II)-β6(III) thumb loop (PHD2: 6 residues; 316-321; CrP4H: 15 residues, 146-160) are of similar length and in the same locations as those of PPHD putida (Fig. 4 A and B and SI Appendix, Fig. S7 A  and B) ; however, an analogous Arg57:Asp130 salt bridge that connects the finger and thumb loops is not present in PHD2 or CrP4H.
The PHD2 C-terminal α-helix is involved in substrate binding and catalysis (16, 25) . The PPHD putida C-terminal loop (residues 201-207, corresponding to PHD2 392-408) directly interacts with EF-Tu, as does the PHD2 C-terminal α-helix with HIF-α CODD (Fig. 4A, Inset) , suggesting evolutionary conservation of a role for the C terminus in substrate recognition.
Comparison of the substrate complexes reveals that conservation is not limited to the enzymes but extends to the bound substrates. Strikingly, the unrelated substrates all adopt closely related conformations in their active site regions when bound to their respective prolyl-hydroxylase partners; EF-Tu (residues 50-57) complexed with PPHD shares a similar orientation and conformation to that of HIF-α (residues 560-567) complexed with PHD2 (backbone atoms rmsd, 0.1 Å) and to that of a proline-rich peptide complexed with CrP4H (backbone atoms rmsd, 0.1 Å; Fig. 4 A and B and SI Appendix, Fig. S6 D and E) . However, there are differences in observed substrate binding for the prolyl-4-hydroxylases (PPHD, PHDs, CP4Hs) and that predicted for prolyl-3-hydroxylases (OGFOD1/Tpa1; SI Appendix, Fig. S7 A and B) . The prolyl-4-hydroxylases have a conserved arginine at their active site opening positioned to hydrogen bond to the carbonyl of the substrate proline (Arg134 PPHD , Arg322 PHD2 , Arg161 CrP4H ). Prolyl-4-hydroxylases also have a conserved tyrosine (Tyr121 PPHD , Tyr310 PHD2 , Tyr140 CrP4H ), the hydroxyl of which points toward the nitrogen of the substrate proline (Fig. 4 A and B and SI Appendix, . Pseudomonas PPHD, human PHD2, and C. reinhardtii P4H (CrP4H) share a conserved mechanism for substrate binding. Overall and active site superimpositions of the PPHD putida (magenta):EF-Tu (cyan) complex and both (A) human PHD2 (sand) in complex with HIF-α CODD (residues 556-574; PDB ID: 3HQR) (green) and (B) CrP4H (green) in complex with proline-rich peptide substrate (PDB ID: 3GZE) (yellow) reveal conservation of the roles of the β2-β3 finger loop and the β5(II)-β6(III) thumb loop, the orientation of the substrate backbone in the active site, and other key substrate binding interactions. Note that although CrP4H does not share a structurally conserved Arg133 PPHD with PPHD, as does PHD2 (Inset), CrP4H does share a conserved Glu109 PPHD (Glu127 CrP4H , Thr296 PHD2 ). (Inset) The PPHD putida and PHD2 C termini interact differently with their substrates. In contrast, the PHD2 C terminus interacts directly with HIF-α CODD (25) . Fig. S6 D and E and S7B) . In contrast, the prolyl-3-hydroxylases have a smaller hydrophobic leucine at the equivalent position to Tyr121 PPHD (Leu156 Tpa1 , Leu152 OGFOD1 ) (29) , which may promote prolyl-3-hydroxylation over prolyl-4-hydroxylation by adjusting the position of the proline within the active site. In the PPHD putida active site, the pyrrolidine ring of Pro54 EF-Tu is observed in a C-4 endo conformation, poised for hydroxylation, as observed in the PHD2:HIF-α and CrP4H:proline-rich peptide complexes (Fig. 4 A and B and SI Appendix, Fig. S6 D and E) (25, 28, 30) , and in contrast to the C-4 exo conformation, as observed for prolyl-hydroxylated HIF-1α when complexed with pVHL (1).
Discussion
The combined results suggest that roles for prolyl-hydroxylation are ancient, extending from EF-Tu in bacteria to, at least, collagen, HIF-α, and ribosomal protein 23 in eukaryotes. The results support growing evidence for the importance of 2OG oxygenases, including PHD homologs, in the regulation of translation, as well as of transcription (5-8, 29, 31-35) . It is notable that the Jumonji C subfamily 2OG oxygenases also play roles in both histone/ chromatin and ribosomal protein modification (5, 36) .
Structurally guided bioinformatic analyses are informative with regard to the distribution of prolyl-hydroxylases. Comparison of the topologies of the prolyl-3-hydroxylases and prolyl-4-hydroxylases for which crystal structures are available reveals conservation not only of the DSBH, Fe(II), and 2OG binding sites but also of other functionally important elements including the β2-β3 finger loop and α-helices that pack against the DSBH (SI Appendix, Fig.  S7 A and B) , enabling assignment of putative prolyl-hydroxylases with a high confidence level. All identified subtypes of prolyl-4-hydroxylases (CP4Hs and PHDs) and prolyl-3-hydroxylases [Leprecans (mammalian collagen prolyl-3-hydroxylases) and OGFOD1s] are ubiquitous in animals, and all but the Leprecans are present in choanoflagellates. However, their presence in prokaryotes is sporadic, and they are apparently absent in archaea (Fig. 5  and SI Appendix, Fig. S8 ).
Given that HIF and collagen exist in animals, but not bacteria, protein prolyl-hydroxylases (and other enzymes catalyzing posttranslational modifications) may have first evolved to catalyze oxidation of highly abundant proteins, such as the switch I loop of EF-Tu, which are part of the translational machinery. Such protein hydroxylases were possibly derived from 2OG oxygenases acting on small molecules (e.g., proline-hydroxylases) (37) , some of which have simpler structures than the protein-hydroxylases (23) . In eukaryotes, the prolyl-hydroxylases evolved divergently to catalyze hydroxylation of collagen and other proteins involved in translational and transcriptional regulation [e.g., Skp1 and ribosomal protein 23 (6) (7) (8) (9) ]. Their role in HIF-α hydroxylation evolved in animals, possibly via fusion of a basic helix-loop-helix domain transcription factor with an EF-Tu, collagen, or Skp1-related or Skp1-derived substrate. The observation that PHD2 interacts with, but apparently does not hydroxylate, eEF2, the eukaryotic counterpart to prokaryotic EF-G, an EF-Tu homolog (15) , is interesting because it may reflect an ancestral relationship between PPHD and EF-Tu. Competition between HIF-α and eEF2 [and potentially other PHD substrates; e.g., pyruvate kinase M2 (38) or centrosomal protein 192 (39) ], may help regulate the hypoxic response in higher animals. Analogous competition is proposed for factor-inhibiting HIF (FIH) catalyzed HIF-1α asparagine hydroxylation, which reduces HIF activity by blocking its interaction with coactivator proteins (1). Factor-inhibiting HIF also takes ankyrin repeat domains as substrates in a manner proposed to enable a robust and tuneable hypoxic response (40) .
The conformational changes observed on substrate binding in the PPHD:EF-Tu complex reveal that major induced fit during 2OG oxygenase catalyzed protein-modification can occur. The observed changes will be useful in designing new types of 2OG oxygenase inhibitors based on various conformational states, rather than active site iron chelators, which make up most reported 2OG oxygenase inhibitors, including PHD inhibitors, in clinical trials (41) .
The finding that PPHD regulates the production of pyocyanin implies that iron regulation in P. aeruginosa may be important in terms of clinically relevant infections. The role of the PHDs in the hypoxic response has been highlighted in part because of medicinal opportunities relating to the treatment of ischemic and related diseases such as anemia (41) . Although regulation of animal PHD activity by iron availability is well-established [cobaltous ion induced erythropoiesis is proposed to be via PHD inhibition (41) ], it has had less prominence. P. aeruginosa infections, which often occur in hypoxic niches, such as in the cystic fibrosis lung (42) , can induce a HIF-mediated hypoxic response in eukaryotic cells by production of small molecule factors, which have been proposed to be cyanide (43) . Pyocyanin induces HIF-α up-regulation in human cells (13) , likely via PHD inhibition, at least in part by iron sequestration. Thus, it seems that during some infections, prolylhydroxylases in both human and bacterial cells may be involved in "cross-talk" involving regulation limited not only by oxygen availability but also by that of iron and, possibly, 2OG (or other tricarboxylic acid cycle intermediate or related compounds) (44) . Therefore, the biological roles of the PHDs and PPHDs likely extend beyond hypoxic sensing in an isolated organism.
From a clinical perspective, the work is relevant to ongoing trials involving PHD inhibitors for anemia treatment (41) . At least some PHD inhibitors inhibit other 2OG oxygenases (41, 45) . There is also increasing use of metal chelators, including orally active compounds (which inhibit the PHDs by iron chelation) (46) , for iron overload diseases. Although our work does not predict what effect, if any, application of clinically applied PHD inhibitors/iron chelators will have on the course of infections by bacteria containing PHD homologs, the potential for effects of PHD inhibitors on infection should be considered.
Materials and Methods
Protein Purification and Crystallization. Recombinant PPHD putida and EF-Tu putida were produced in E. coli and purified using Ni-affinity and size-exclusion chromatography. For purification of the PPHD:EF-Tu complex, cell pellets containing either PPHD putida or EF-Tu putida were colysed with Mn(II) and NOG to prevent EF-Tu hydroxylation and were purified in the same way. For details of crystallization conditions, data collection and processing, and refinement statistics, see SI Appendix, SI Materials and Methods, and Tables S1 and S2. P. aeruginosa Phenotypic Analyses. P. aeruginosa PAO1 wild-type and PPHD insertional knockout mutant strain were grown (28°C) in various concentrations of 2,2-bipyridine (0, 1, 5, and 25 mM); the optical density (600 nm, OD 600 ) was assayed every 60 min. For pyocyanin quantification, 5-mL cultures of P. aeruginosa wild-type and PA0310 mutant strains grown to stationary phase were extracted with 3 mL CHCl 3 and then back-extracted with 1 mL 0.2 HCl, and then the aqueous phase was decanted and its absorbance measured at 520 nm. For global translation rate assays, 1-mL cultures of P. aeruginosa wild-type and PA0310 mutant strains were grown to log phase (OD 600 = 0.5), and the rate of incorporation of [ 35 S]methionine (10 μCi/mL) was measured by scintillation counting.
Determination of EF-Tu as a PPHD Substrate. Hydroxylation assays for PPHD putida contained 10 μM PPHD, 100 μM EF-Tu 44- Fig. S5D ). See SI Appendix, SI Materials and Methods.
